Avet Lifesciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVET LIFESCIENCES, and what generic and branded alternatives to AVET LIFESCIENCES drugs are available?
AVET LIFESCIENCES has thirty-eight approved drugs.
Drugs and US Patents for Avet Lifesciences
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avet Lifesciences | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE;INJECTION | 204040-001 | Dec 12, 2013 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Avet Lifesciences | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 211682-001 | May 10, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Avet Lifesciences | BICNU | carmustine | INJECTABLE;INJECTION | 017422-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.